Advertisement
"MediPurpose is dedicated to improving the quality of life for thoseliving with diabetes. Our SurgiLance safety lancets are used by them forregular glucose testing," says MediPurpose CEO Patrick Yi.
Advertisement
JDRF is the world's largest charitable funder of and advocate for type 1(juvenile) diabetes research worldwide. Type 1 Diabetes is a disease whichstrikes children suddenly and requires multiple injections of insulin daily ora continuous infusion of insulin through a pump. Since its inception in 1970,JDRF has raised more than $1.9 billion to fund direct research.
"With the generous support of companies such as MediPurpose, JDRF cancontinue its mission to discover, develop and deliver therapeutics to improvethe lives of people with diabetes," said Marie Davis, executive director ofthe organization's Metro Saint Louis / Greater Missouri Chapter.
About MediPurpose
MediPurpose develops, manufactures and markets innovative healthcaresolutions valued by its customers. The company is known for introducingquality safety medical devices that protect healthcare professionals fromsharps injury. Founded in 1999, the company achieved rapid success with itsSurgiLance safety lancet, quickly becoming one of the top leaders in the USsafety lancet market and establishing solid distribution channels worldwide.
The SurgiLance safety lancet has found long-term success in all sectors ofthe healthcare market and has provided more than 500 million consumers with asafe, simple and effective tool for blood testing. MediPurpose currentlyoffers six color-coded lancets, which are used for capillary blood samplingfor a range of testing requirements.
MediPurpose maintains offices in the US, Singapore, the UK, France andSpain. As a globally recognized innovator, MediPurpose has developed a menu ofservices to assist inventors and growing medical device companies successfullydesign, patent, manufacture and sell their products.
For more information on MediPurpose, visit www.medipurpose.com.
SOURCE MediPurpose